Andrin Oswald MD

Dr. Andrin Oswald is the director of Life Sciences Partnerships, overseeing the foundation’s engagements with corporations.
Prior to joining the foundation, he was CEO and division head of Novartis Vaccines and Diagnostics from 2008 until its acquisition by GSK in 2015. He was a member of the executive committee of Novartis. In September 2013, Andrin also became chairman of the board of the Novartis Foundation for Sustainable Development. Prior to that he served as CEO of Speedel holding AG and global head of Pharmaceutical Development Franchises in the Novartis Pharmaceuticals Division, both in Switzerland.
Andrin joined Novartis in 2005 as assistant to the chairman and CEO. Before his appointment as head of Development Franchises, he served as head of the Country Pharmaceuticals Organization (CPO) and country president for Novartis in South Korea. He joined Novartis from McKinsey & Company, Switzerland, where he was an associate principal.